MAST4 and nasopharyngeal carcinoma: Survival analysis showed that the higher expression of CD27 (P =0.001), CEP85L (P < 0.001), DOK3 (P <0.001), MAST4 (P<0.001), SEC24A (P <0.001), and UPK3B (P <0.001) in PanCK-expressing regions of NPC patients correlated with better prognosis.